Results 1 to 10 of about 229,509 (282)

Coronary microcirculatory dysfunction after percutaneous coronary intervention: pathogenesis, diagnosis, and therapeutic strategies. [PDF]

Front Cardiovasc Med
BoYuan J, TingTing W, ChengJun H, XinYi H, YuShan C.   +4 more
europepmc   +3 more sources

Clopidogrel and Percutaneous Coronary Interventions

JAMA: The Journal of the American Medical Association, 2003
case fatality rates in inhaled anthrax can approach 100%. Anthrax bacteria, after being inhaled, use three toxins— protective antigen, oedema factor, and lethal factor—to enter, appropriate, and kill alveolar macrophages. Seven copies of protective antigen assemble and facilitate entry of oedema factor and lethal factor into macrophages.
Brian Y L, Wong, Eric A, Cohen
  +12 more sources

Single centre experience of rotablation-assisted left main percutaneous coronary intervention. [PDF]

Am Heart J Plus
Sohil MM, Masood I, Goyal D, Rashid H.
europepmc   +2 more sources

Guidelines for Percutaneous Coronary Interventions [PDF]

European Heart Journal, 2005
In patients with stable CAD, PCI can be considered a valuable initial mode of revascularization in all patients with objective large ischaemia in the presence of almost every lesion subset, with only one exception: chronic total occlusions that cannot be crossed. In early studies, there was a small survival advantage with CABG surgery compared with PCI
Silber, Sigmund, Albertsson, Per, Avilés, Francisco F., Camici, Paolo G., Colombo, Antonio, Hamm, Christian, Jørgensen, Erik, Marco, Jean, Nordrehaug, Jan-Erik, Ruzyllo, Witold, Urban, Philip, Stone, Gregg W., Wijns, William, Deckers, Jaap, Bassand, Jean-Pierre, Battler, Alexander, Bertrand, Michel, Betriu, Amadeo Gibert, Cokkinos, Dennis, Danchin, Nicolas, Di Mario, Carlo, de Feyter, Pim, Fox, Kim, Indolfi, Ciro, Karsch, Karl, Steg, Philippe Gabriel, Tendera, Michal, Van de Werf, Frans, Verheugt, Freek W. A., Widimski, Petr   +29 more
openaire   +3 more sources

Percutaneous Coronary Intervention

Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2018
Cardiac catheterization is a procedure by which information is obtained from the heart by passing fine plastic tubes (occasionally other instruments) either near to or within the heart, to introduce contrast to cardiac structures to understand their anatomy and function better, to measure pressures, and/or to measure oxygen saturations in different ...
Cheerag Shirodaria, Sam Dawkins
  +6 more sources

Bivalirudin in percutaneous coronary intervention [PDF]

Vascular Health and Risk Management, 2006
Bivalirudin is a member of the direct thrombin inhibitor group of anticoagulants. It has been evaluated as an alternative to unfractionated and low-molecular-weight heparins in the settings of percutaneous coronary intervention (PCI) and acute coronary syndrome (ACS). Results of clinical trials to date suggest bivalirudin is a viable alternative to the
Lehman, Sam, Chew, Derek Peng
openaire   +3 more sources

Percutaneous Coronary Interventions in Women

Current Atherosclerosis Reports, 2023
Abstract Purposeof Review Cardiovascular disease is the leading cause of morbidity and mortality among women globally. Numerous studies show ongoing disparities in diagnosis, management, and outcomes of ischemic heart disease in women compared to men.
Joodi, Golsa, Palimar, Sristi, Press, Marcella Calfon   +2 more
openaire   +2 more sources

Imaging in Percutaneous Coronary Intervention

Reviews in Cardiovascular Medicine, 2022
Intracoronary imaging (ICI) use during percutaneous coronary intervention (PCI) has been shown to effectively improve cardiovascular outcomes, particularly for high-risk subgroups. However, data from randomized controlled trials are limited and the overall utilization rate of ICI remains variable between different countries and centers.
Mohan Satish, Anastasios Roumeliotis, David Power, Anton Camaj, Johny Nicolas, Daniel Feldman, Davis Jones, Keisuke Yasumura, Frans Beerkens, Saman Suleman, George Dangas   +10 more
openaire   +3 more sources

Appropriateness of Percutaneous Coronary Intervention [PDF]

JAMA, 2011
Despite the widespread use of percutaneous coronary intervention (PCI), the appropriateness of these procedures in contemporary practice is unknown.To assess the appropriateness of PCI in the United States.Multicenter, prospective study of patients within the National Cardiovascular Data Registry undergoing PCI between July 1, 2009, and September 30 ...
Paul S, Chan, Manesh R, Patel, Lloyd W, Klein, Ronald J, Krone, Gregory J, Dehmer, Kevin, Kennedy, Brahmajee K, Nallamothu, W Douglas, Weaver, Frederick A, Masoudi, John S, Rumsfeld, Ralph G, Brindis, John A, Spertus   +11 more
openaire   +2 more sources

Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. [PDF]

, 2017
BackgroundElevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown.Methods and resultsBaseline demographics and 2-year MACE were ...
Ang, Lawrence, Behnamfar, Omid, Lin, Felice, Mahmud, Ehtisham, Palakodeti, Samhita, Patel, Mitul P, Pourdjabbar, Ali, Reeves, Ryan R   +7 more
core   +1 more source